What is the potential of daratumumab in combination therapy for myeloma?
Progession of AML treatment over the past decades
Shifting the focus in lymphoma treatment
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
The challenges of transplantation for patients with multiple myeloma (MM)